StoneX Group’s Pomdoctor Ltd POM Stock Holding History

StoneX Group’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-565	Closed	-$3K	–	1307
2025 Q4	$3K	Buy	+565	New	+$36.9K	﹤0.01%	1058

Other funds holding POM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

StoneX Group's POM Position: Q1 2026 in Review

StoneX Group sold out of Pomdoctor Ltd (POM) in Q1 2026, closing a stake of 565 shares — an estimated $3K sold.

StoneX Group first reported a position in POM in Q4 2025 and held it in 1 quarter. The position peaked at $3K in Q4 2025. 10 funds tracked by Wall St. Rank hold POM as of Q1 2026.

StoneX Group reported no remaining Pomdoctor Ltd position as of Q1 2026 after selling out during the quarter.
StoneX Group sold 565 Pomdoctor Ltd shares in Q1 2026, an estimated $3K.
StoneX Group first reported a position in Pomdoctor Ltd in Q4 2025 and held it in 1 quarter.
StoneX Group's Pomdoctor Ltd position peaked at $3K in Q4 2025.
10 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.